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Abstract
Macrophage colony-stimulating factor (M-CSF) promotes mononuclear phagocyte survival and proliferation. The
transcription factor Nuclear Factor-kappaB (NF-kB) is a key regulator of genes involved in M-CSF-induced mononuclear
phagocyte survival and this study focused at identifying the mechanism of NF-kB transcriptional activation. Here, we
demonstrate that M-CSF stimulated NF-kB transcriptional activity in human monocyte-derived macrophages (MDMs) and
the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional
PKCa/b inhibitor Go ¨-6976, overexpression of dominant negative PKCa constructs and PKCa siRNA reduced NF-kB activity in
response to M-CSF. Interestingly, Ro-31-8220 reduced Ser276 phosphorylation of NF-kBp65 leading to decreased M-CSF-
induced monocyte survival. In this report, we identify conventional PKCs, including PKCa as important upstream kinases for
M-CSF-induced NF-kB transcriptional activation, NF-kB-regulated gene expression, NF-kB p65 Ser276 phosphorylation, and
macrophage survival. Lastly, we find that NF-kB p65 Ser276 plays an important role in basal and M-CSF-stimulated NF-kB
activation in human mononuclear phagocytes.
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Introduction
Monocytes are produced in the bone marrow and circulate in
blood for 24–48 hours [1]. In the absence of serum, monocytes die
via apoptosis [1,2]. Macrophage colony-stimulating factor (M-
CSF) stimulates mononuclear phagocyte survival and differentia-
tion [3]. Importantly, M-CSF-mediated cell survival and activa-
tion is associated with a variety of human diseases, including
atherosclerosis, transplant vascular sclerosis and breast cancer
metastasis [4,5,6].
We previously identified that NF-kB activation is important in
M-CSF-induced monocyte survival [7]. In addition to its role in
mononuclear phagocyte survival, the transcription factor NF-kB
regulates numerous genes that play important roles in cellular
signaling, stress response, cell growth, survival, differentiation and
inflammation [8]. There are five members in the NF-kB family:
RelA/p65, p50, p52, c-Rel and RelB. The most common
activating complex is the p50/p65 heterodimer, driven by the
activation domain in the NF-kB p65 subunit. NF-kB p65 regulates
important developmental processes [9,10]. Mice lacking NF-kB
p65 die in utero and have extensive liver damage via enhanced
apoptosis [9]. Embryonic macrophages from NF-kB p65 null mice
are susceptible to TNFa-induced apoptosis which is rescued by
overexpressing the NF-kB p65 subunit [10]. Moreover, inhibiting
NF-kB induces cell death in many cell types and cytokine-
independent survival is mediated by constitutively active NF-kBi n
murine macrophages [11].
In monocytes and macrophages, NF-kB is an important
transcriptional factor for expression of cytokines and cell surface
receptors [12]. However, unlike resting T-cells, NF-kBi s
constitutively present in the nuclei of primary monocytes and
monocytic cell lines in the absence of exogenous stimuli as
demonstrated by mobility shift analysis [13]. Similarly, constitu-
tively active NF-kB was observed in human alveolar macrophages
[14].
In the classic/canonical pathway, the NF-kB p50/p65 complex
is sequestered in the cytosol by IkBa [15]. Upon stimulation by
cytokines or UV radiation, IkBa is phosphorylated, ubiquitinated,
and degraded, releasing NF-kB p50/p65 to translocate to the
nucleus and transactivate target genes. After its release from IkBa,
NF-kB p65 can undergo post-translational modification to activate
gene transcription. The role of NF-kB p65 phosphorylation
on NF-kB transcriptional activity varies by stimulus, time of
stimulation and cell type [16]. Previous research shows that
phosphorylation of NF-kB p65 at Ser276, Ser529 or Ser536 plays
an important role in regulating transcriptional activity of NF-kB
[17]. In TNFa-treated murine fibroblasts, Ser276 of NF-kB p65 is
phosphorylated by MSK1 to enhance NF-kB transcriptional
activity [18]. In macrophages treated with endotoxin, NF-kB
transcription activity is associated with phosphorylation on Ser276
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IKKb respectively[16,19]. In human T cells, NF-kB p65 is
constitutively phosphorylated on Ser536 to facilitate NF-kB p65
nuclear translocation following cellular stimulation [20]. Accumu-
lating evidence reveals that NF-kB p65 phosphorylation at Ser276
is crucial for its transcriptional activity. Upon nuclear transloca-
tion, phosphorylation of Ser276 on NF-kB p65 by PKA recruits
the transcription co-activator, p300 to potentiate NF-kB-regulated
gene transcription [21]. However, other studies show that PKA
inhibits NF-kB-regulated gene expression by stabilizing IkBa
[22,23]. Interestingly, the serine/threonine kinase Pim-1 directly
phosphorylates NF-kB p65 at Ser276 by stabilizing to prevent
ubiquitin-proteasome degradation [24]. Several other phosphor-
ylation sites are also described to enhance NF-kB gene
transactivation [25].
H e r e ,w ei n v e s t i g a t et h er o l eo fp r o t e i nk i n a s eC( P K C )i nM -
CSF-stimulated NF-kB activation. PKC proteins are multifunc-
tional kinases that differ in structure, function and co-factor
requirement [26]. PKCs are involved in diverse cell responses,
including cell growth, survival, differentiation and development
[27]. The 12 closely related enzymes of the PKC family are
divided into three classes: conventional (cPKCs: ab I bII and c
require Ca
2+ and diacylglycerol (DAG); novel (nPKCs: d, e, g, h
and m) require DAG; and atypical (aPKCs: j, i and l) require
neither Ca
2+ nor DAG. Monocytes and macrophages predom-
inantly express conventional PKC isoforms (PKCa PKCbI
and PKCbII) and novel PKCs (PKCd and PKCe). Conventional
PKCs regulate differentiation of the human promyelocytic
leukemia cell line HL60 to macrophages [28]. PKCa induces
IL-1a,i N O Sa n dT N F a mRNA production after lipopoly-
saccharide (LPS) exposure [29]. In addition, accumulating
evidence suggests that conventional PKCs like PKCa have anti-
apoptotic functions. For example, PKCa is overexpressed in a
variety of tumor cells including gliomas, liver, and lung [30,31].
In epithelial cells, inhibition of PKCa induces PKCd-dependent
apoptosis [31]. Interestingly, in human monocytes and pre-
monocytic THP-1 leukemia cells, novel PKCs like PKCd
have the opposite effect on cell survival, Voss et al showed
that PKCd directly phosphorylates caspase-3 and promotes
etoposide-induced apoptosis [32]. Moreover, knockout mouse
studies suggest that another novel PKC, PKCe is critically
involved in early LPS-mediated signaling in activated macro-
phages [33].
Previously, we reported that M-CSF promotes monocyte
survival through the activation of the PI3-K/AKT pathway [3].
In addition to AKT activation, M-CSF stimulates PKC in human
monocytes and increases NF-kB DNA binding [34]. However,
whether PKC and/or NF-kB activation is critical in M-CSF-
stimulated mononuclear phagocyte survival and/or differentiation
is unclear. In other cells, PKC plays an important role in NF-kB
activation and cell survival [35], however the specific mechanisms
of this activation and the biological effects on cellular phenotype
are not known. Therefore, we focused at understanding the role of
PKC in the regulation of NF-kB activation and M-CSF-induced
monocyte survival.
Here we demonstrates that M-CSF upregulated the NF-kB
transcription and cell survival in human and mouse macrophages.
This activity was reduced by the conventional, but not novel, PKC
inhibitors, dominant negative PKCa constructs or PKCa siRNA.
Conventional PKC regulated NF-kB-regulated gene expression
and phosphorylation of Ser276 of NF-kB p65 occurred in an M-
CSF-dependent fashion correlating with its maximal transcrip-
tional activity. Furthermore, PKCa-regulated phosphorylation of
Ser276 of NF-kB p65 plays an important role in regulating its
activity in mononuclear phagocytes and murine embryonic
fibroblasts.
Results
M-CSF Induces NF-kB Transcriptional Activity in Human
Monocyte–Derived Macrophages (MDMs) and Mouse
Macrophage Cell Line, RAW 264.7
To determine if M-CSF induced NF-kB DNA binding in
human macrophages, we performed EMSA analysis on nuclear
lysates from M-CSF-treated MDMs. Similar to previous reports
[11], nuclear NF-kB constitutively bound DNA in non-stimulated
monocytes (Figure 1A). Interestingly, adding M-CSF did not alter
NF-kB DNA binding by EMSA. In contrast, after transiently
transfecting human MDMs with pNF-kB-SEAP constructs
containing four NF-kB consensus binding sequences, M-CSF
treatment of the transfected cells resulted in a 2.3-fold increase in
SEAP release in the culture media compared to PBS (vehicle)-
treated transfected MDMs (Figure 1B). As a control, the pTAL-
SEAP construct lacking NF-kB binding sites was used. Cells
transfected with the pTAL-SEAP construct did not produce SEAP
in the absence or presence of M-CSF (Figure 1B).
We next investigated whether M-CSF induced NF-kB activity
in the mouse macrophage cell line, RAW 264.7. RAW 264.7 cells
were transfected with either the NF-kB-SEAP reporter or control
pTAL-SEAP construct. As shown in Figure 1C, M-CSF treatment
of RAW 264.7 cells increased NF-kB reporter activity by 2.5-fold
over that of non-treated cells. Together, our data demonstrate that
M-CSF induced NF-kB transcriptional activity in macrophages.
PKC Inhibition Reduces NF-kB Activity in Human MDMs
and RAW 264.7 Cells
Since NF-kB is activated by PKC in several cell types [36], we
next determined if M-CSF-induced NF-kB transcriptional activity
was dependent on PKC activation and if calcium, a co-factor for
conventional PKC isoform activation, was important. In addition,
because of the number of conventional PKCs existing within
mononuclear cells, pharmacological inhibitors of PKC family
activation was used to determine the relationship of PKC
activation to M-CSF-induced cellular survival. MDMs were
transfected with the pNF-kB-SEAP reporter and then treated
with the general PKC inhibitor, Ro-31-8220; the conventional
PKCa/b inhibitor Go ¨-6976; or the intracellular calcium blocker
BAPTA/AM. Ro-31-8220 significantly suppressed M-CSF-in-
duced NF-kB activity compared to cells treated with M-CSF alone
(Figure 2A). In addition, Go ¨-6976 and BAPTA/AM also blocked
NF-kB activity in M-CSF-treated MDMs. Trypan blue exclusion
analysis did not indicate cell death suggesting that this suppression
was not due to non-specific toxicity. These data indicate that M-
CSF mediated NF-kB activation through calcium-dependent
conventional PKC activation.
We next investigated whether PKC inhibition affected NF-kB
activity in the mouse macrophage cell line, RAW 264.7. Similar to
MDMs, PKC inhibitors Ro-31-8220, Go ¨-6976 and BAPTA/AM
reduced M-CSF-induced NF-kB activity in a dose-dependent
manner in RAW 264.7 macrophages (Figure 2B). To ensure that
PKC specifically regulated NF-kB p65 and not the closely related
family member, c-Rel, we co-transfected c-Rel and NF-kB-SEAP
constructs into the Raw 264.7 cell line and measured NF-kB
activity in response to M-CSF. There was no increased NF-kB
activity in cells expressing c-Rel (Figure S1). These observations
indicate that PKC functioned upstream of NF-kB p65 in MDMs
and RAW 264.7 cells.
PKC Activates NF-kB
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Since PKC and NF-kB are critical in cell survival [37,38], we
hypothesized that M-CSF promoted cell survival through PKC in
human MDMs. To detect apoptosis, the expression of cleaved
caspase-3, a marker of apoptosis, was analyzed in the presence or
absence of M-CSF and PKC inhibitors. In MDMs pretreated with
PKC inhibitors (Ro-31-8220, Go ¨-6976, or BAPTA/AM) and
stimulated with M-CSF, cleaved caspase-3 was elevated to levels of
cells treated with vehicle alone (Figure 3A). In contrast, cells
incubated with M-CSF and vehicle had less cleaved caspase-3 than
cells incubated with vehicle alone or M-CSF with PKC inhibitors.
These data supported the hypothesis that M-CSF-induced NF-kB
activity was regulated by conventional PKCs, not novel PKCs.
To confirm that PKC inhibition decreased cell survival, cells
were treated with M-CSF in the absence or presence of PKC
inhibitors and then also examined for apoptosis by Annexin V/PI
staining. PKC inhibitors in the presence of M-CSF reduced the
number of Annexin V/PI negative MDMs compared to cells
treated with M-CSF alone (Figure 3B). These observations further
suggested that MDM survival is promoted by M-CSF and
critically involves conventional PKCs and NF-kB activity.
M-CSF-Induces PKCa Kinase Activity
Since our data suggested that conventional PKCs were involved
in activating NF-kB in response to M-CSF in primary human
macrophages, we next investigated whether the conventional
PKC, PKCa was a downstream target of M-CSF in human
MDMs. PKCa was immunoprecipitated from human MDMs at
the indicated time points (Figure 4), and then a PKC kinase assay
was performed using a fluorescein-tagged peptide as a substrate.
As shown in Figure 4 (upper panel), the peptide substrate was
maximally phosphorylated within 10 minutes of stimulation (1.8-
fold over resting cells, lower panel), and then returned to basal
levels by 15 minutes. This effect was not seen in M-CSF-
stimulated monocytes when isogenic antibodies (IgG) were used
for immunoprecipitation. Western blots of identical samples using
an antibody recognizing PKCa demonstrated that equal amounts
of PKCa were assayed (Figure 4, middle panel).
M-CSF-Dependent Activation of PKC Does Not Regulate
the Classical NF-kB p65 Activation Pathway
Canonical activation of NF-kB occurs via phosphorylation and
degradation of IkBa leading to the release and nuclear
translocation of the NF-kB p50/p65 heterodimer to transactivate
target genes [37,39]. Since conventional PKC activity was
important in regulating M-CSF-induced NF-kB activation, we
Figure 1. M-CSF induces NF-kB transcriptional activity in
macrophages. (A) Nuclei were extracted from human MDMs treated
without or with M-CSF for 15 or 30 minutes. NF-kB DNA binding activity
was analyzed by EMSA Shown is a representative blot from three
independent experiments. NS: non-stimulated. (B) Human MDMs
transiently transfected with pTAL-SEAP or pNF-kB-SEAP constructs
were treated with M-CSF in X-vivo medium and incubated for 6 hours
before the collection of medium. NF-kB activity was analyzed by
measuring the amount of SEAP secreted into the medium and data are
expressed as fold increase of SEAP activity over that in pTAL-SEAP
transfected resting cells. (C) RAW 264.7 cells were transiently
transfected with pTAL-SEAP or pNF-kB-SEAP construct. Cells were
serum starved for 4 hours prior to 2 hours stimulation with mouse
recombinant M-CSF (100 ng/ml). Culture media was collected to
measure SEAP production. Data are expressed mean 6 S.E.M, for three
independent experiments.
doi:10.1371/journal.pone.0028081.g001
PKC Activates NF-kB
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PKC. Cells were treated with cyclohexamide (CHX) to inhibit
protein synthesis of IkBa, and its degradation was followed. As
shown in Figure 5A, PKC inhibition with Ro-31-8220 did not
alter M-CSF-induced IkBa degradation, suggesting that M-CSF-
induced PKC activity augmented NF-kB transcriptional activity
by an alternative pathway, like post-translational modification of
NF-kB p65.
Figure 2. Inhibition of PKC reduces NF-kB activity in M-CSF stimulated macrophages. (A) Human MDMs transfected with pNF-kB-SEAP
were pre-incubated with inhibitors; Ro-31-8220, Go ¨-6976, or BAPTA/AM for 30 minutes prior to 6 hours M-CSF stimulation. (B) RAW 264.7 cells
transfected with the pNF-kB-SEAP construct were pre-incubated with inhibitors for 30 minutes prior to 2 hours of stimulation with mouse
recombinant M-CSF. The NF-kB activity was analyzed by measuring SEAP production in the medium and data are expressed as fold increase of SEAP
activity over that in pTAL-SEAP transfected resting cells. The graph represents mean 6 S.E.M for three independent experiments. *The p-values of
cells treated with inhibitors/M-CSF compared to vehicle/M-CSF were #0.05.
doi:10.1371/journal.pone.0028081.g002
PKC Activates NF-kB
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Since M-CSF did not regulate NF-kB activation by influencing
IkBa, we next sought to determine if M-CSF affected NF-kB p65
by post-translational mechanisms. Thus, we examined the phos-
phorylation of NF-kB p65 with specific phospho-NFkB p65
(Ser276 and Ser536) antibodies. M-CSF induced the phosphor-
ylation of Ser276 but not Ser536 of NF-kB p65 in MDMs.
Compared to vehicle, the general PKC inhibitor Ro-31-8220
reduced Ser276 phosphorylation, but not Ser536, phosphorylation
in M-CSF-stimulated cells (Figure 5B). Furthermore, M-CSF-
stimulated NF-kB p65 phosphorylation at residue Ser276 in RAW
264.7 cells was also PKC dependent (Figure 5C). These studies
suggested that PKC(s) regulated Ser276 phosphorylation but not
Ser536 in both human MDMs and mouse macrophages after M-
CSF stimulation.
We next performed cellular fractionation to identify the cellular
location of phosphorylated NF-kB p65 in Raw 264.7 cells. Non-
phosphorylated NF-kB p65 was located inboth cytosolic and nuclear
fractions, but phosphorylated Ser276 and Ser536 NF-kBp 6 5w a s
primarily located in nuclear fraction after M-CSF stimulation
(Figure 5D). Notably, constitutive phosphorylation of Ser536 NF-
kB p65 was found in these cells. Importantly, Ro-31-8220 reduced
M-CSF-induced Ser276 phosphorylation of NF-kBp 6 5i nb o t ht h e
cytosolic and nuclear fractions, while M-CSF-induced NF-kBp 6 5
Ser536 phosphorylation was present in the nucleus regardless of PKC
inhibition. These observations indicate that M-CSF-induced Ser276
Figure 3. Inhibition of PKC or NF-kB induces apoptosis in
MDMs. (A) MDMs were pre-incubated in RPMI medium containing
inhibitors (Ro-31-8220: 5 mM, Go ¨-6976: 5 mM, BAPTA/AM: 2.5 mM) for
30 minutes prior to the addition of M-CSF. As a control, untreated cells
were incubated with dimethyl sulfoxide (DMSO). Cell lysates were
resolved by SDS-PAGE and immunoblotted with antibody recognizing
the active cleaved form of caspase-3. The blots were reblotted with b-
actin that served as a loading control. The ratio of active caspase-3
bands (17 kD and 19 kD) to b-actin control was determined by
densitometry analysis (bottom panel). Data represents the mean 6
S.E.M from two independent donors. (B) Apoptosis of the treated MDMs
was also measured by Annexin V-FITC and propidium iodine (PI)
staining and analyzed by flow cytometry. The percentage of surviving
cells (Annexin V/PI negative) for the cells treated with vehicle/M-CSF
was arbitrarily set as 100. Data shown represent the mean 6 S.E.M from
three independent experiments. *The p-values of inhibitors/M-CSF
compared to vehicle/M-CSF were #0.05.
doi:10.1371/journal.pone.0028081.g003
Figure 4. M-CSF activates PKCa in human MDMs. MDMs treated
with M-CSF (100 ng/ml) for varying amounts of time were lysed and
immunoprecipitated using anti-PKC antibody or control IgG antibody.
One half of the samples was used to analyze PKC kinase activity using a
fluorescein tagged peptide and visualized by agarose gel electropho-
resis (top panel), while the other half was subjected to Western blot
analysis to confirm equal amounts of PKCa were immunoprecipitated
from each sample (middle panel). The kinase assay was quantitated
using Quantity One software (Bio-Rad) (bottom panel). Data represents
the average fold increase of PKCa activity in non-stimulated samples
compared to M-CSF-treated MDM 6 S.E.M for three independent
experiments. NS: non-stimulated. * The p-values of M-CSF stimulated
compared to non-stimulated were #0.05.
doi:10.1371/journal.pone.0028081.g004
PKC Activates NF-kB
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in mononuclear phagocytes. The purity ofthe cytosoland nuclear cell
fractions was confirmed by immunoblotting with GAPDH and
Lamin B, respectively (Figure 5D).
M-CSF-dependent PKC Regulates NF-kB-targeted Genes
NF-kB induces a number of downstream genes, including the
IkB family. Among the IkB molecules, IkBa is highly induced by
NF-kB activation [40]. Having shown that PKC regulated NF-
kB activity in M-CSF-stimulated MDMs, we next determined
whether inhibition of PKC activity decreased expression of NF-
kB-regulated genes. We treated both MDMs and RAW 264.7 cells
with the PKC inhibitor Ro-31-8220 for 30 minutes and then
stimulated with M-CSF. IkBa gene was measured by qRT-PCR.
As shown in Figures 6A and 6B, M-CSF enhanced IkBa gene
expression and PKC inhibition by Ro-31-8220 decreased IkBa
Figure 5. M-CSF-induced PKC activity does not regulate IkBa degradation but regulates the phosphorylation of NF-kB p65 at
Ser276. (A) MDMs were pretreated with cycloheximide (CHX) in the absence or presence of Ro-31-8220 for 30 minutes prior to M-CSF stimulation
for the indicated times. Whole cell lysates were subjected to Western blotting with anti-IkBa antibody. Data are representative of three independent
experiments. (B) MDMs were pretreated with either vehicle or Ro-31-8220 for 30 minutes before the addition of M-CSF for 10 minutes. Whole cell
lysates were resolved by SDS-PAGE and phospho-Ser276 or phospho-Ser536 of NF-kB p65 was detected using phospho-specific antibodies to either
residue of NF-kB p65. (C) Whole cell lysates of RAW 264.7 cells treated with vehicle control or Ro-31-8220 in the absence or presence of M-CSF were
subjected to Western blot analysis with phospho-Ser276 or phospho-Ser536 NF-kB p65 antibodies. (D) Cytosolic and nuclear fractions of RAW 264.7
were obtained from the treated cells and immunoblotted for phospho-NF-kB. The purity of the cytosolic and nuclear fractions was confirmed by
immunoblotting with GAPDH and Lamin B, respectively. Shown are representative blots from three independent experiments.
doi:10.1371/journal.pone.0028081.g005
PKC Activates NF-kB
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RAW 264.7 (B) cells were pretreated with Ro-31-8220 or solvent control DMSO for 30 minutes prior to M-CSF stimulation for the indicated times. Total
RNA was isolated and converted to cDNA. Real-time RT PCR was performed using primers for IkBa, BCL-xl or GAPDH. Data are expressed as relative
fold increase of IkBa or BCL-xl gene expression upon treatment over non-stimulated cells. Data represent the mean 6 S.E.M for three independent
experiments.
doi:10.1371/journal.pone.0028081.g006
PKC Activates NF-kB
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28081gene expression in both MDMs and RAW 264.7 cells (p,0.01),
demonstrating that PKC affected NF-kB-regulated gene expres-
sion in macrophages.
To further define the role of PKC in mediating human MDM
survival in response to M-CSF, we examined the expression of the
anti-apoptotic gene BCL-xL, which is also regulated by NF-kB. As
shown in Figure 6C, Ro-31-8220 reduced M-CSF-stimulated
BCL-xL expression compared to cells treated with M-CSF and the
vehicle control DMSO (p,0.05).
Identification of PKCa as the Upstream Activator of NF-
kB in Myeloid Cells
Even though the PKC family consists of 10 members, finding
that PKCa/b inhibitors and intracellular calcium inhibitors
reduced M-CSF-induced NF-kB activity, suggested PKCa was
involved in NF-kB activation after M-CSF treatment. To confirm
the role of PKCa in NF-kB activation in macrophages, constructs
for either wildtype (WT)-PKCa or kinase-deficient (KD)-PKCa
was co-transfected with the pNF-kB-SEAP reporter gene and
SEAP secretion was measured. As shown in Figure 7A, MDMs co-
transfected with pNF-kB-SEAP and WT-PKCa had a 1.8-fold
increase in NF-kB transcriptional activity after M-CSF activation
compared with NS cells (p=0.05), similar to M-CSF-treated cells
expressing only pNF-kB-SEAP. Transfecting human macrophages
with the KD-PKCa construct significantly reduced M-CSF-
induced NF-kB activity compared to WT-PKCa transfected cells
(p=0.016). Similarly, RAW 264.7 cells transfected with WT-
PKCa had 2.5-fold more NF-kB transcriptional activity after M-
CSF activation compared to unstimulated RAW 264.7 cells (NS)
transfected with WT-PKCa (Figure 7B). Expression of the KD-
PKCa construct into RAW 264.7 cells reduced M-CSF-induced
NF-kB activity to 1.5-fold (p=0.045) compared to cells transfected
with WT PKCa.
Cell survival was also examined in MDMs expressing either
WT-PKCa or KD-PKCa constructs by Annexin V-FITC and PI
staining. As expected, M-CSF increased MDM survival as
measured by the percent of Annexin V/PI negative cells.
Similarly, expression of WT-PKCa protected cells from apoptosis.
In contrast, expression of KD-PKCa decreased M-CSF-induced
cell survival (p,0.01) (Figure 7C).
Next, we examined the effect of expressing the PKCa constructs
on NF-kB phosphorylation. As shown in Figure 7D, expression of
KD-PKCa in RAW 264.7 cells did not affect the constitutive
phosphorylation at Ser536 of NF-kB p65, but attenuated the
phosphorylation at Ser276. Expression of WT-PKCa did not
effect the phosphorylation of either residue with or without M-
CSF stimulation. These observations demonstrate that PKCa is
important in M-CSF-regulated cell survival and NF-kB activation
and likely regulated through phosphorylation of Ser276 of NF-kB
p65.
To further validate the impact that PKCa played in M-CSF-
induced NF-kB transcriptional activity, we next employed PKCa
siRNA treatment of MDM or RAW cells. A pool of specific PKCa
siRNA were transfected into MDM or Raw 264.7 cells in the
presence or absence or M-CSF. Reducing native PKCa expression
decreased M-CSF-induced NF-kB transcriptional activity in both
MDM (Figure 7E) (p=0.012) and Raw 264.7 cells (Figure 7F)
(p=0.01). We also examined cell survival of the MDMs by
Annexin V-FITC and PI staining after PKCa siRNA transfection.
As shown in Figure 7G, M-CSF-induced MDM survival was
reduced in the cells transfected with PKCa siRNA compared with
cells transfected with control siRNA (p=0.047). In Figure 7H, we
confirmed that PKCa siRNA transfection decreased PKCa
protein expression in both MDM and Raw 264.7 cells. Our
results indicated that PKCa regulated NF-kB activation and M-
CSF-regulated cell survival.
PKC is Essential in Regulating NF-kB Activity
M-CSF-dependent PKC activity facilitated NF-kB p65 phos-
phorylation at Ser276 but not Ser536. To confirm the role of PKC
and p65 Ser276 phosphorylation on NF-kB activity, we co-
transfected the NF-kB-SEAP construct with either WT NF-kB
p65 or NF-kB p65 276S/A constructs in Raw 264.7 cells, then
treated cells with the PKC inhibitor Ro-31-8220 in the absence or
presences of M-CSF. As expected in cells transfected with vector
control, inhibiting PKC reduced M-CSF-stimulated NF-kB
activity compared to cells treated with M-CSF and the vehicle
DMSO (p=0.001) (Figure 8A). In contrast, expressing WT NF-kB
p65 (p65 WT) increased NF-kB activity, while the general PKC
inhibitor Ro-31-8220 decreased this NF-kB activity (p=0.001).
Notably, the introduction of NF-kB p65 276 S/A construct
significantly reduced NF-kB activity compared with the WT NF-
kB p65 construct (p=0.005) and M-CSF treatment was unable to
overcome this inhibition.
Furthermore, we co-transfected the NF-kB-SEAP construct
along with either the WT NF-kB p65, NF-kB p65 276S/A or NF-
kB p65 536S/A constructs into a NF-kB p652/2 murine
fibroblast cell line and measured NF-kB activity. As predicted,
expression of WT NF-kB p65 (p65 WT) in NF-kB p652/2 cell
line constitutively activated NF-kB compared to cells transfected
with vector control without any stimulation (Figure 8B). In
comparison, transfecting the NF-kB p65 276S/A construct
reduced NF-kB activity by 5-fold (p=0.006, WT NF-kB p65 vs.
NF-kB p65 276S/A), while expressing the NF-kB p65 536S/A
construct increased NF-kB activity in the p652/2 cells to levels
similar to WT NF-kB p65 transfected cells.
Since M-CSF-induced PKC activation regulated NF-kB activity
via Ser276 residue of NF-kB p65 in primary human MDMs and
RAW 264.7 cells, we next examined if this occurred in NF-kB
p652/2 fibroblasts in response to a native stimulus for these cells,
Figure 7. PKCa regulates phosphorylation of NF-kB p65 at Ser276. (A) MDM or (B) RAW 264.7 cells were transiently transfected with pNF-kB-
SEAP along with either WT-PKCa or the kinase-deficient (KD)-PKCa construct at a 1:5 ratio. Cells were serum starved and stimulated with M-CSF and
then SEAP secretion in the medium was measured. Data is from of three independent experiments. The p-value of cells transfected with KD
compared to those transfected with WT was 0.05. (C) MDMs were removed from the plate using accutase and apoptosis of MDMs was measured by
flow cytometry using Annexin V-FITC and propidium iodine (PI). (D) Whole cell lysates from the transfected RAW 264.7 cells were subjected to
Western blot analysis with phospho-Ser276 or phospho-Ser536 NF-kB p65 antibodies. Blots were immunoblotted with PKCa to determine equal
protein expression for the PKCa constructs. b-actin served as a loading control. Shown is a representative blot from three independent experiments.
(E) MDM or (F) RAW 264.7 cells were transiently transfected with a pNF-kB-SEAP along with either 100 nM PKCa siRNA or control siRNA for 20-
24 hours. Cells were serum starved for 2-4 hours and stimulated with 100 ng/ml M-CSF for 6 hours for MDM or RAW 264.7 for 2 hours and then SEAP
secretion in the medium was measured. Shown is data of three independent experiments. (G) MDMs were removed from the plate using accutase
and apoptosis of MDMs was measured by Annexin V-FITC and propidium iodine (PI) staining and analyzed by flow cytometry. (H) Whole cell lysates
from the transfected MDM and RAW 264.7 cells were subjected to Western blot analysis with PKCa antibody. b-actin served as a loading control.
Shown is a representative blot from at least three independent experiments.
doi:10.1371/journal.pone.0028081.g007
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PLoS ONE | www.plosone.org 10 December 2011 | Volume 6 | Issue 12 | e28081TNFa. NF-kB activity was measured in the WT NF-kB p65 or
NF-kB p65 276S/A transfected cells treated with TNFa in the
absence or presence of Ro-31-8220 (Figure 8C). As expected,
TNFa increased NF-kB activity in NF-kB p652/2 cells
expressing WT p65 and (p=0.001) PKC inhibitors decreased
NF-kB activity to the non-stimulated (NS) level (p=0.007).
Introducing NF-kB p65 276 S/A constructs significantly reduced
NF-kB activity compared with the WT NF-kB p65 construct
(p=0.001). Notably, TNFa failed to increase NF-kB activity in the
NF-kB p652/2 cells expressing NF-kB p65 276S/A constructs.
These observations are similar to macrophages overexpressing the
NF-kB p65 276S/A (Figure 8A). Our data demonstrate that
Ser276 of NF-kB p65 is essential in regulating NF-kB activity and
suggests that PKC regulates NF-kB activity by modulating the
phosphorylation of NF-kB p65 at Ser276 residue.
Discussion
NF-kB transcriptional activity is important in regulating
intracellular signaling, stress response, proliferation, survival,
differentiation and inflammation [8]. To regulate gene transcrip-
tion, NF-kB p50/p65 heterodimers translocate to the nucleus from
the cytoplasm, however, their translocation is not sufficient to
activate gene transcription. Post-translational modification of NF-
kB heterodimers such as phosphorylation or acetylation also
contributes to its transcriptional activity [41,42,43]. Because NF-
kB constitutively translocates to the nucleus in monocytic lineage
[13] and activates gene transcription and survival in murine
macrophages [11], we sought to determine how M-CSF affected
NF-kB transcriptional activity in human MDMs and whether this
activation regulated their survival. The present study demonstrat-
ed that M-CSF stimulated PKCa kinase upstream of NF-kB
transcriptional activity in primary human MDMs and RAW 264.7
cells. We showed inhibition of conventional PKCs by PKC
inhibitors, kinase deficient PKCa or PKCa siRNA blocked M-
CSF-induced cell survival and NF-kB-regulated gene expression.
This block correlated with a reduction in M-CSF-induced
phosphorylation of NF-kB p65 at Ser276. Consistent with these
findings the dominant negative PKCa constructs also inhibited
NF-kB p65 phosphorylation at Ser276 but not at Ser536 resulting
in reduced NF-kB transcriptional activation and M-CSF-induced
MDM survival. A simplified proposed cartoon model in Figure 9
demonstrates that M-CSF induced monocytes survival is regulated
by activating NF-kB p65 phosphorylation at Ser276 via PKC.
Finally, in a NF-kB p652/2 fibroblast cell line, we confirmed
that the Ser276 residue of NF-kB p65 is important and essential
for PKC modulation of NF-kB activity. More compelling is that
we observed a similar regulation between two different cell
lineages in our study.
Post-translational modification of NF-kB p65 regulates its
activating or repressing effects on gene expression. Among the
seven reported putative NF-kB p65 phosphorylation sites, five
increase nuclear translocation, DNA binding and NF-kB tran-
scriptional activity [17]. Similar to our finding, Zhong et al. found
that in response to LPS, NF-kB p65 is phosphorylated at the
highly conserved Ser276 residue by the catalytic subunit of PKA
[16]. In addition to PKA, Ser276 can be phosphorylated by
MSK1 in the nucleus upon TNFa treatment [18]. Phosphoryla-
tion of NF-kB p65 at Ser536 occurs in response to many
inflammatory stimuli as well as kinases, IKKa, IKKb and RSK1
[17,18,19,20,21]. Notably, in addition to phosphorylating Ser276
of NF-kB, our study revealed that M-CSF also modulated the
phosphorylation of the NF-kB p65 subunit at Ser536, however,
PKC inhibitors or kinase deficient PKCa constructs did not affect
this phosphorylation event. Moreover, mutant constructs contain-
ing a point mutation at Ser536 of NF-kB p65 did not reduce NF-
kB activity in cells lacking endogenous NF-kB p65, while the NF-
kB p65 276S/A construct did reduce NF-kB activity in these cells.
Therefore, specific post-translational modification of NF-kB p65 is
likely to regulate transcriptional activation in response to specific
stimuli [15,43].
It is notable that M-CSF activated NF-kB p65 Ser276
phosphorylation and transcriptional activation in a PKCa-
dependent manner. PKCa is a member of the conventional
PKC family of protein kinases that are critical for cell growth,
differentiation and cell death. PKCa primarily modulates anti-
apoptotic and proliferation signals following cytokine treatment in
various cell types [42]. Expression of PKCa attenuates apoptosis in
Figure 9. Proposed model for M-CSF-induced monocyte
survival via PKC regulation by activating NF-kB p65 phosphor-
ylation at Ser276.
doi:10.1371/journal.pone.0028081.g009
Figure 8. NF-kB p65 Ser276 is essential in regulating NF-kB activity. (A) Raw 264.7 cell line was transiently transfected with pNF-kB-SEAP
along with empty vector or plasmid encoding either NF-kB p65 WT or NF-kB p65 276S/A. The cells were transfected for 18-24 hours, serum starved
for 4 hours, and then incubated with 10 mM of Ro-31-8220 for 30 minutes prior to treatment with 100 ng/ml of M-CSF for 2 hours and SEAP secretion
in the medium was measured. (B) NF-kB p652/2 cell line was transiently transfected with pNF-kB-SEAP along with empty vector or plasmid
encoding either NF-kB p65 WT, NF-kB p65 276S/A, or NF-kB p65 536S/A. The cells were cultured for 24 hours and then serum starved for 4 hours.
Cells were then incubated in fresh DMEM medium for 2 hours and SEAP secretion in the medium was measured. The results shown are fold change
over empty vector + pTAL-SEAP. (C) NF-kB p652/2 cell line was transiently transfected with pNF-kB-SEAP with either empty vector or plasmid
encoding either NF-kB p65 WT or NF-kB p65 276S/A. The cells were transfected for 24 hours and serum starved for 4 hours, and then incubated with
10 mM of Ro-31-8220 for 30 minutes prior to treatment with 10 ng/ml of TNFa. The supernatant were collected after 2 hours of treatment and SEAP
secretion in the medium was measured. The results shown are the fold change over empty vector + pNF-kB-SEAP. Data shown are mean 6 S.E.M for
at least three independent experiments performed in duplicate.
doi:10.1371/journal.pone.0028081.g008
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potentiates apoptosis [42]. In our studies using conventional
PKC inhibitors and dominant negative PKCa constructs, PKCa
was critical in M-CSF-induced macrophage survival by inducing
Ser276 phosphorylation of NF-kB p65 in both primary human
MDMs and Raw 264.7 cells. We also demonstrated PKC
inhibition downregulated NF-kB-induction of the anti-apoptotic
gene BCL-xL. Consistent with our finding, others reported NF-kB
regulated the gene expression of many anti-apoptotic proteins
including other BCL-2 family members and inhibitor of apoptosis
(IAP) proteins which are regulators of apoptosis and function
upstream of caspases [44]. It has been shown that phosphorylation
of p65 at Ser276 prevents its degradation by ubiquitin-mediated
proteolysis and promotes cell survival in HeLa cells [24]. In
addition to BCL-xL expression as examined in this study, we are
evaluating the possibility that PKCa-regulated NF-kB activity
upregulates additional anti-apoptotic genes in an M-CSF-
dependent fashion to modulate cell survival.
The use of inhibitors and siRNA in our study has not ruled out
that other conventional PKCs might also be important in M-CSF-
induced NF-kB activation and macrophage survival. In contrast to
the actions of PKCa activation of other conventional PKC
isoforms, like PKCbI/bII, appear necessary for macrophage
apoptosis. The PKCbI/bII isoforms are expressed in apoptotic
U937 myelomonocytic cells [45]. The human myeloid cell line
HL-525 which is devoid of endogenous PKCbII is resistant to
TNFa-induced apoptosis [46]. Re-expression of PKCbII in HL-
525 cells restores their susceptibility to TNFa-induced apoptosis
implying that PKCbII is pro-apoptotic and may be required to
induce macrophage apoptosis.
Recent studies demonstrated that NF-kB transcriptional activity
can be regulated by phosphorylation of the NF-kB p65 subunit in
the absence of IkBa degradation [47]. By this pathway, phosphor-
ylation of NF-kB regulates its interaction with other components of
the basal transcriptional machinery without affecting its capability
to bind DNA [21]. Since NF-kB can bind the promoters of
numerous gene targets, post-translational modification of NF-kB
p65 may affect its interaction with other proteins, refining the
expression of gene targets. We did not find that PKC was involved
in IkBa degradation or NF-kB p65 nuclear translocation induced
by M-CSF, but that M-CSF-induced phosphorylation of NF-kB
p65 at Ser276 was dramatically reduced by the conventional PKC
inhibitor and kinase deficient PKCa and by siRNA towards PKCa.
Current studies are underway to delineate the protein complexes
formed by activated NF-kB and other transcriptional co-activators
in response to M-CSF and PKC activation. Recently studies
indicated that the non-canonical pathway was activated during
human monocyte-macrophage differentiation [48]. During this
process, expression of IKKa among other proteins, is elevated
leading to increased p52 NF-kB (relB) expression through partial
proteolytic degradation of the p100 NF-kB protein. Thus, it is
possible that M-CSF regulates monocyte survival through both the
canonical and non-canonical NF-kB pathways, which will be a
focus in future research.
We previously showed that M-CSF reduced caspase-3 and -9
activity and prevented monocyte apoptosis [3]. This study reveals
that treatment of monocytes with conventional PKC inhibitors, or
overexpression of kinase-deficient PKCa blocked M-CSF-induced
cell survival. Our data revealed that conventional PKCs are
upstream of NF-kB activation in response to M-CSF and mediate
post-translational activation of NF-kB p65 by phosphorylating
Ser276 to regulate gene transcription and cell survival. Thus, our
observation may provide insight in potential therapeutic targets for
inflammatory diseases.
Materials and Methods
Materials
Recombinant human M-CSF was purchased from R&D
Systems (Minneapolis, MN). Ro-31-8220, Go ¨-6976, Rotterin,
and BAPTA/AM were obtained from Calbiochem (San Diego,
CA). Low endotoxin RPMI and X-vivo serum free medium were
obtained from Lonza Walkersville Inc (Walkersville, MD). Fetal
bovine serum (FBS, certified ,0.06 endotoxin units/ml endotoxin
levels) was purchased from Atlanta Biological (Lawrenceville, GA).
All other cell culture reagents were obtained through Invitrogen
(Carlsbad, CA). PKCa NF-kB p65, Lamin B, b-actin, and
GAPDH antibodies, anti-mouse and rabbit IgG-HRP conjugated
antibodies, and PKCa siRNA were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Phospho-NFkB p65 (Ser276 or
Ser536) antibodies were purchased from Cell Signaling Technol-
ogy (Danvers, MA). DNA constructs pTAL-SEAP and pNF-kB-
SEAP were obtained from Clontech (Mountian View, CA).
Expression vectors containing CMV-p65 WT, CMV-p65 276S/
A and CMV-p65 536S/A were cloned in pBa5e Puro vector or
pFLAG-CMV-2 vector as described previously [49]. Kinase
deficient CMV-PKCa (KD-PKCa) or wild type pCMV-PKCa
(WT-PKCa) were generous gifts from Alexandra C. Newton
(University of California, San Diego, CA). IkBa (NFKBIA) and
GAPDH primers for real-time RT-PCR were obtained from
SABiosciences (Frederick, MD). A pool of mouse or human PKCa
specific siRNA were purchased from Santa Cruz Biotechnology
(Santa cruz, CA).
Cell Culture
The murine macrophage cell line RAW 264.7 was purchased
from ATCC (Manassas, VA). RAW 264.7 cells were maintained in
RPMI supplemented with 5% FBS and antibiotic-antimycotic
(1000 U/ml penicillin, 1000 mg/ml streptomycin sulfate, and
250 ng/ml amphotericin B) at 37uC. Mouse embryonic fibroblasts
(MEFs) cell line lacking specific NFkB signaling subunits NF-kB
p65 (p652/2 cell line) [50] were cultured in DMEM medium
supplemented with 10% FBS and antibiotic-antimycotic solution.
Purification of Peripheral Blood Monocytes and
Monocyte-Derived Macrophages (MDMs)
Monocytes were isolated from source leukocyte packs obtained
from the American Red Cross as described previously [51].
Monocytes used in real time PCR experiments and transfection
experiments were purified by positive selection using CD14
Monocyte Isolation Kit from Miltenyi Biotech (Auburn, CA)
(.90% pure). In some experiments, monocytes were isolated by
clumping method (70% pure). To obtain monocyte-derived
macrophages (MDMs), monocytes were cultured in RPMI-1640
medium containing 10% FBS, and 10 mg/ml polymyxin B and
20 ng/ml M-CSF.
Electrophoresis of the Mobility Shift Analysis (EMSA)
Nuclear extracts were isolated from MDMs by using a nuclear
extraction kit according to the manufacturer’s instruction from
Active Motif (Carlsbad, CA). Briefly, MDMs were lysed in
hypotonic lysis buffer (20 mM Hepes, pH 7.5; 5 mM NaF,
10 mMN a 2MoO4 0.5% NP-40 and 0.1 mM EDTA), and then
nuclei were resuspended in lysis buffer supplemented with 0.5 mM
DTT and 0.2 mM PMSF. The NF-kB consensus oligonucleotides
(sense: AGTTGAGGGGACTTTCCCAGGC; antisense: GCCT-
GGGAAAGTCCCCTCAACT) labeled with
32P by T4 poly-
nucleokinase (Promega, Madison, WI) were incubated with
nuclear extracts in binding buffer (10 mM Tris pH 7.6, 1 mM
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30uC for 30 minutes. The free DNA and DNA-protein mixtures
were resolved in 5% native polyacrylamide gels in 0.56 TBE
buffer (45 mM Tris, 45 mM boric acid and 1 mM EDTA,
pH 8.3) by electrophoresis. The gel was dried and subjected to
autoradiography analysis.
Transient Transfection of RAW 264.7 Cells
RAW 264.7 cells were seeded in 12-well plates in RPMI
medium containing 5% FBS one day prior to transfection,
Secreted alkaline phosphatase (SEAP) reporter plasmids pTAL-
SEAP or pNF-kB-SEAP were transfected into cells using Qiagene
Effectene or Attractene transfection kit (Qiagen, Valencia, CA)
according to the manufacturer’s protocol. For co-transfection
studies, PKCa or NF-kB p65 constructs were mixed at a ratio of
5:1 with the reporter plasmid. For siRNA transfection, 100 nM of
PKCa siRNA or control siRNA were used. Cells were incubated
with the transfection reagents for 16–24 hours, washed and
starved in RPMI without FBS for 4 hours. Samples were then
stimulated with 100 ng/ml M-CSF for 4 hours at which point the
medium was collected for the SEAP analysis. For inhibition
studies, cells were pre-incubated with inhibitors for 30 minutes
before M-CSF treatment. On average, we realized 30–40%
transfection efficiency as confirmed by GFP expression in Raw
264.7 cells.
Transient Transfection of Primary Human Monocytes
Monocytes were transfected using the human monocyte Amaxa
nucleofector kit (Lonza Walkersville Inc, Walkersville, MD) as
previously described [51]. Briefly, monocytes were resuspended in
Amaxa Nucleofactor solution at a density of 20610
6 cells/ml, and
2 mg of total plasmid DNA 100 nM of PKCa siRNA or control
siRNA was added and transfected using program Amaxa Y-01.
For co-transfection studies, PKCa or NF-kB p65 constructs were
mixed at a ratio of 5:1 with the reporter plasmid. Immediately
after transfection, cells were washed with 1 ml of RPMI medium
containing 2 mM glutamine and 10% FBS or serum free LGM
medium (Lonza Walkersville Inc.) then plated at 4610
5 cells/well
in 24-well plates. The original medium was replaced by serum free
LGM medium without or with M-CSF (100 ng/ml) one hour
later. The next day, cell-free supernatants were collected for the
SEAP analysis. Cells were stained with Annexin V/propidium
iodide (PI). For the inhibition studies, cells were pre-incubated
with inhibitor for 30 minutes in X-vivo medium prior to the
addition of M-CSF.
Secreted Alkaline Phosphatase (SEAP) Analysis
Secreted alkaline phosphatase activity was analyzed by Great-
Escape SEAP kit according to the manufacturer’s instruction.
Briefly, medium was diluted in the dilution buffer and heated to
65uC to inactivate endogenous phosphatases then incubated with
the substrate for 30 minutes. The chemiluminence signal was
recorded using a luminometer.
Annexin V/PI Apoptosis Assay
Cell apoptosis assay was performed as described previously [51]
using the Annexin V–FITC apoptosis detection kit (BD PharMin-
gen, San Diego, CA). Briefly, human monocytes (5610
6) were
incubated with inhibitors for 30 minutes in X-vivo medium and
restimulated with 100 ng/ml M-CSF overnight. The cells were
removed from the culture dish using Accutase (eBioscience, San
Diego, CA) and stained with Annexin V–FITC and PI and
analyzed by flow cytometry (FACSCalibur; BD PharMingen).
Annexin V-FITC and PI double negative cells were considered
non-apoptotic cells for statistical analysis.
Western Blot Analysis
Cells were washed with PBS and resuspended in cell lysis buffer.
(Cell Signaling Technology) and incubated for 10 minutes on ice
then centrifuged to remove the insoluble fraction. The protein
concentration was determined by the BCA protein assay (Bio-Rad,
Hercules, CA). Cell lysates were separated by SDS-PAGE on 10%
polyacrylamide gels and then transferred onto nitrocellulose
membranes and subjected to Western blotting. The immuno-
blotted proteins were detected by ECL reagent (GE Healthcare
Bio-Sciences Corp., Piscataway, NJ).
Analysis of PKCa Kinase Activity
Human MDMs were starved for 2 hours before stimulation
with M-CSF (0–60 minutes), then washed with cold PBS and
removed from the plates. The cells were resuspended in lysis buffer
(20 mM Tris, 5 mM MgCl2, 1 mM EGTA, 20 mM b-glycerol
phosphate, 1 mM PMSF 2 mg/ml aprotinin and 2 mg/ml
leupeptin, pH 7.5), sonicated and centrifuged to obtain whole cell
lysates, which were then immunoprecipitated with anti-PKCa
antibody and protein G-agarose (Invitrogen). Immune complexes
were washed twice, and PKCa activity was analyzed by non-
radioactive Peptag assay kit (Promega). Briefly, kinase buffer,
activator, peptide protection solution and Peptag peptide were
incubated with the immune complexes at 30uC for 30 minutes.
Reactions were stopped by boiling for 10 minutes and samples
were separated on 0.8% agarose gel. Phosphorylated peptide
migrated toward the anode (+), while non-phosphorylated peptide
migrated toward the cathode (2). Fluorescein-tagged peptides
were visualized by UV light.
RNA Isolation and Quantitative Real-time PCR
MDMs or RAW 264.7 cells were serum-starved overnight or for
2 hours, respectively, prior to incubating with inhibitors for
30 minutes. The cells were restimulated with 100 ng/ml M-CSF
and total mRNA was extracted from cells with Trizol (Invitrogen)
and 1–2 mg of total RNA was used to synthesized cDNA using
SuperScript III (Invitrogen). Quantitative real-time (qRT)-PCR
was performed using SYBR Green Master Mix (Applied
BioSystems, Carlsbad, CA). The reactions were performed using
an ABI PRIZM 7700 machine with software Sequence Detector
version 1.7 (Applied Biosystems). The target gene values were
normalized to the values of GAPDH as a housekeeping gene and
expressed as relative fold increase 2
(2DDCt) over the non-stimulated
samples (NS).
Statistical Analysis
Statistical comparisons were performed using analysis of
variance testing (Minitab software, State Park, PA or SPSS16
software, SPSS Inc. Chicago, IL). Statistical significance was
defined as p#0.05.
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Supporting Information
Figure S1 Expression of c-Rel does not enhance M-CSF-
induced NF-kB transcriptional activity in macrophages.
RAW 264.7 cells were transiently transfected with pTAL-SEAP,
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were serum starved for 4 hours prior to the stimulation with
mouse recombinant M-CSF (100 ng/ml) for 2 hours. Culture
media was collected to measure SEAP production. Data are
expressed as fold increase of SEAP activity over that in pTAL-
SEAP transfected resting cells. The graph represents mean 6
S.E.M for two independent experiments done in triplicates.
(TIF)
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